Stem Cell Institute Co-Founders and Companies Banned from Marketing Stem Cell Treatments and Ordered to Pay More Than $5.1 Million for Refunds and Civil Penalties
January 08, 2025
January 08, 2025
WASHINGTON, Jan. 8 -- The Federal Trade Commission issued the following news release:
Under federal district court orders announced today, the co-founders of the Stem Cell Institute of America and several related companies are banned from marketing stem cell therapy in the future. The order resolves a complaint filed jointly by the Federal Trade Commission and Georgia Attorney General's Office. A separate order requires the defendants to pay $5,155,146 in both civil penalties a . . .
Under federal district court orders announced today, the co-founders of the Stem Cell Institute of America and several related companies are banned from marketing stem cell therapy in the future. The order resolves a complaint filed jointly by the Federal Trade Commission and Georgia Attorney General's Office. A separate order requires the defendants to pay $5,155,146 in both civil penalties a . . .